Clinical trials
Recruiting Uterine Cervical Neoplasms trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Institute of Molecular and Translational Medicine, Czech Republic | 2 |
| General University Hospital, Prague | 1 |
| Institut Claudius Regaud | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Nikola Janovska | 1 |
| The Central and Eastern European Gynecologic Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 7 |
| Uterine Cervical Dysplasia | 3 |
| Papillomavirus Infections | 2 |
| Adenocarcinoma | 1 |
| Carcinoma, Adenosquamous | 1 |
| Oropharyngeal Neoplasms | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.